Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
19.43
+0.80 (4.29%)
At close: May 12, 2025, 4:00 PM
19.43
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $212.83 million as of May 12, 2025. Its market cap has increased by 279.37% in one year.
Market Cap
212.83M
Enterprise Value
47.35M
1-Year Change
279.37%
Ranking
Category
Stock Price
$19.43
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has increased from $203.10M to $212.83M, an increase of 4.79%. That is a compound annual growth rate of 0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 241.60M | 27.56% |
| Dec 31, 2024 | 189.40M | 163.79% |
| Dec 29, 2023 | 71.80M | 32.47% |
| Dec 30, 2022 | 54.20M | -36.01% |
| Dec 31, 2021 | 84.70M | -3.64% |
| Dec 31, 2020 | 87.90M | -30.73% |
| Dec 31, 2019 | 126.90M | 94.63% |
| Dec 31, 2018 | 65.20M | -52.62% |
| Dec 29, 2017 | 137.60M | -20.65% |
| Dec 30, 2016 | 173.40M | -26.34% |
| Dec 31, 2015 | 235.40M | 15.90% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.87B |
| Johnson & Johnson | 370.90B |
| UnitedHealth Group | 343.41B |
| AbbVie | 335.67B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.47B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |